Kendall Donaldson (Bascom Palmer Eye Institute) discusses the current limitations and future landscape of cataract surgery at ESCRS 2019.
1. What are the limitations of cataract surgery? (0:04)
2. What is on the horizon for presbyopia correction in upcoming years? (0:41)
3. What is the most exciting change in intraocular lens (IOL) calculations and methods for post-operative adjustment? (1:34)
4. Where do you see cataract surgery 10 years from now? (2:34)
Support: No funding was received in the production of this video.
Disclosures: Kendall Donaldson discloses the following financial interests: Alcon, Johnson and Johnson, Allergan, Biotissue, Kala Pharmaceuticals, Eyevance, Omeros, SUN
Share this Video
Related Videos In Cataract Surgery
Eric Donnenfeld, Hawaiian Eye and Retina 2021: Next-generation Extended Depth of Focus Intraocular Lenses
It was a pleasure to speak with Eric Donnenfeld (Ophthalmic Consultants of Long Island, NY, USA) about advantages and limitations of new extended depth of focus intraocular lenses and the future of this technology. Questions What factors need to be considered when selecting an extended depth of focus (EDOF) intraocular lens (IOL) for a patient […]
Eric Donnenfeld, Hawaiian Eye and Retina 2021: Extended Depth of Focus Intraocular Lenses Following Cataract Surgery
We were delighted to speak to Eric Donnenfeld (Ophthalmic Consultants of Long Island, NY, USA) about limitations of multifocal intraocular lenses (IOLs) following cataract surgery, and how extended depth of focus IOLs have overcome these limitations. Questions What are the limitations of multifocal intraocular lenses (IOLs) following cataract surgery? (00:16) How have extended depth of […]
Jorge L Alió, EGS 2020 – Innovations in Premium IOLs
We caught up with Jorge L. Alió (Miguel Hernández University of Alicante, Elche, Spain) to find out the most promising recent advances in premium IOLs. Questions Could you give us a brief overview of your experience with premium IOLs? (0:05) What are the most promising recent advances and what issues with premium IOLs remain to […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!